Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00853515 · ClinicalTrials.gov registry record · NA

Goal-directed Fluid Resuscitation in Acute Pancreatitis

A NA study, sponsored by Brigham and Women's Hospital.

Terminated
Registry status
NA
Development phase
40
Enrollment target

NCT00853515: Clinical Trial NA study, sponsored by Brigham and Women's Hospital.

NCT00853515 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00853515, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.

TERMINATED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative approaches to early fluid resuscitation for patients with acute pancreatitis.

Interventions

  • OTHER Goal-directed fluid resuscitation

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-03
Est. Completion 2010-06
Phase NA
Brigham and Women's Hospital

937 total trials

Why NCT00853515 stopped before completion

NCT00853515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Goal-directed fluid resuscitation is the first listed.

NCT00853515 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00853515 about?

NCT00853515 is a clinical study titled "Goal-directed Fluid Resuscitation in Acute Pancreatitis". Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative a...

What is the current status of trial NCT00853515?

This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2009-03. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00853515?

The interventions under investigation include: Goal-directed fluid resuscitation (OTHER).

Who is sponsoring clinical trial NCT00853515?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00853515's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00853515, the US trial registry maintained by the National Library of Medicine. NCT00853515 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.